Symbol:
Lpo
Name:
lactoperoxidase
RGD ID:
1310051
Description:
Predicted to enable thiocyanate peroxidase activity. Predicted to be involved in defense response to bacterium and detection of chemical stimulus involved in sensory perception of bitter taste. Predicted to be located in basolateral plasma membrane and cytoplasm. Predicted to be active in extracellular space. Orthologous to human LPO (lactoperoxidase); INTERACTS WITH 17alpha-ethynylestradiol; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC287610
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
LPO (lactoperoxidase)
HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Lpo (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Lpo (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
LPO (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
LPO (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Lpo (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LPO (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
LPO (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Lpo (lactoperoxidase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
DSCAM (DS cell adhesion molecule)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
LPO (lactoperoxidase)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Lpo (lactoperoxidase)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
epx (eosinophil peroxidase)
Alliance
DIOPT (Ensembl Compara|OrthoFinder)
Drosophila melanogaster (fruit fly):
cysu
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA)
Caenorhabditis elegans (roundworm):
pxn-1
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
Pxn
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Caenorhabditis elegans (roundworm):
pxn-2
Alliance
DIOPT (Ensembl Compara|OrthoFinder|PANTHER)
Drosophila melanogaster (fruit fly):
cd
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 73,104,170 - 73,124,683 (-) NCBI GRCr8 mRatBN7.2 10 72,606,950 - 72,626,220 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 72,606,944 - 72,626,535 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 77,217,402 - 77,236,990 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 76,722,350 - 76,741,938 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 72,186,856 - 72,206,440 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 75,100,385 - 75,120,247 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 75,100,385 - 75,120,247 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 74,982,141 - 75,002,010 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 76,099,137 - 76,118,724 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 76,113,946 - 76,141,334 (-) NCBI Celera 10 71,519,507 - 71,539,099 (-) NCBI Celera Cytogenetic Map 10 q26 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Lpo Rat Alzheimer's disease 1 ISO RGD:1320729 8554872 ClinVar Annotator: match by term: Alzheimer disease type 1 ClinVar PMID:15108282|PMID:24033266|PMID:25741868|PMID:26764160|PMID:26822949|PMID:30487145|PMID:31980526|PMID:32531373|PMID:32758447|PMID:32758448|PMID:34426522|PMID:6260268|PMID:9766845 Lpo Rat hereditary breast ovarian cancer syndrome ISO RGD:1320729 8554872 ClinVar Annotator: match by term: Breast-ovarian cancer, familial, susceptibility to, 1 ClinVar PMID:38922859 Lpo Rat intellectual disability ISO RGD:1320729 8554872 ClinVar Annotator: match by term: Intellectual disability ClinVar PMID:25741868|PMID:37071997 Lpo Rat Joubert syndrome 1 ISO RGD:1320729 8554872 ClinVar Annotator: match by term: Familial aplasia of the vermis ClinVar PMID:28492532 Lpo Rat Myeloperoxidase Deficiency ISO RGD:1320729 8554872 ClinVar Annotator: match by term: Myeloperoxidase deficiency ClinVar PMID:15108282|PMID:24033266|PMID:25741868|PMID:26764160|PMID:26822949|PMID:30487145|PMID:31980526|PMID:32531373|PMID:32758447|PMID:32758448|PMID:34426522|PMID:6260268|PMID:9354683|PMID:9766845
Only show annotations with direct experimental evidence (0 objects hidden)
Lpo Rat (S)-colchicine decreases expression ISO RGD:1320729 6480464 Colchicine results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat (S)-naringenin increases expression ISO RGD:1320729 6480464 naringenin results in increased expression of LPO mRNA CTD PMID:24561720 Lpo Rat (S)-naringenin multiple interactions ISO RGD:1320729 6480464 Paraquat inhibits the reaction [naringenin results in increased expression of LPO mRNA] CTD PMID:24561720 Lpo Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1320730 6480464 1,2-Dimethylhydrazine results in decreased expression of LPO mRNA CTD PMID:22206623 Lpo Rat 1,2-dimethylhydrazine multiple interactions ISO RGD:1320730 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LPO mRNA CTD PMID:22206623 Lpo Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of LPO mRNA CTD PMID:17557909 Lpo Rat 17beta-estradiol affects expression ISO RGD:1320729 6480464 Estradiol affects the expression of LPO protein CTD PMID:16584521 Lpo Rat 17beta-estradiol decreases expression ISO RGD:1320729 6480464 Estradiol results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LPO mRNA CTD PMID:26945725 Lpo Rat 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Plant Preparations] results in increased expression of LPO mRNA CTD PMID:26945725 Lpo Rat 17beta-estradiol multiple interactions ISO RGD:1320729 6480464 [Estradiol co-treated with Medroxyprogesterone] affects the expression of LPO protein CTD PMID:16584521 Lpo Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LPO mRNA CTD PMID:34747641 Lpo Rat 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 AHR gene mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPO mRNA] CTD PMID:34256052 Lpo Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPO mRNA CTD PMID:34256052 Lpo Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1320729 6480464 bisphenol S results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat 5-fluorouracil decreases expression ISO RGD:1320729 6480464 Fluorouracil results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat acrylamide multiple interactions EXP 6480464 [Acrylamide co-treated with INS protein] results in increased expression of LPO protein CTD PMID:38604440 Lpo Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of LPO mRNA CTD PMID:23630614 Lpo Rat aflatoxin B1 decreases expression ISO RGD:1320729 6480464 Aflatoxin B1 results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Pyrogallol results in increased activity of LPO protein] CTD PMID:35944648 Lpo Rat barium sulfate increases expression EXP 6480464 Barium Sulfate results in increased expression of LPO mRNA; Barium Sulfate results in increased expression more ... CTD PMID:29463257 Lpo Rat benzidine increases metabolic processing ISO RGD:1320729 6480464 LPO protein results in increased metabolism of benzidine CTD PMID:15606142 Lpo Rat benzo[a]pyrene increases methylation ISO RGD:1320729 6480464 Benzo(a)pyrene results in increased methylation of LPO promoter CTD PMID:27901495 Lpo Rat benzo[a]pyrene decreases methylation ISO RGD:1320729 6480464 Benzo(a)pyrene results in decreased methylation of LPO 5' UTR CTD PMID:27901495 Lpo Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LPO mRNA CTD PMID:25181051 Lpo Rat bisphenol A multiple interactions EXP 6480464 bisphenol A promotes the reaction [Dietary Fats results in increased activity of LPO protein] CTD PMID:35945320 Lpo Rat bisphenol A increases methylation ISO RGD:1320729 6480464 bisphenol A results in increased methylation of LPO gene CTD PMID:31601247 Lpo Rat bisphenol A increases expression ISO RGD:1320730 6480464 bisphenol A results in increased expression of LPO mRNA CTD PMID:38074096 Lpo Rat bisphenol A decreases expression ISO RGD:1320729 6480464 bisphenol A results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat bisphenol AF decreases expression ISO RGD:1320729 6480464 bisphenol AF results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of LPO mRNA CTD PMID:19167457 Lpo Rat carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of LPO mRNA CTD PMID:24911292 Lpo Rat ceric oxide increases expression EXP 6480464 ceric oxide results in increased expression of LPO mRNA; ceric oxide results in increased expression more ... CTD PMID:29463257 Lpo Rat cerium trichloride multiple interactions ISO RGD:1320729 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of LPO mRNA CTD PMID:28954213 Lpo Rat cerium trichloride increases expression ISO RGD:1320729 6480464 cerous chloride results in increased expression of LPO mRNA CTD PMID:28954213 Lpo Rat CGP 52608 multiple interactions ISO RGD:1320729 6480464 CGP 52608 promotes the reaction [RORA protein binds to LPO gene] CTD PMID:28238834 Lpo Rat cisplatin decreases expression ISO RGD:1320729 6480464 Cisplatin results in decreased expression of LPO mRNA CTD PMID:27594783 Lpo Rat clobetasol increases expression ISO RGD:1320730 6480464 Clobetasol results in increased expression of LPO mRNA CTD PMID:27462272 Lpo Rat copper atom decreases expression EXP 6480464 Copper results in decreased expression of LPO mRNA CTD PMID:30556269 Lpo Rat copper(0) decreases expression EXP 6480464 Copper results in decreased expression of LPO mRNA CTD PMID:30556269 Lpo Rat coumarin decreases phosphorylation ISO RGD:1320729 6480464 coumarin results in decreased phosphorylation of LPO protein CTD PMID:35688186 Lpo Rat diethylstilbestrol decreases expression ISO RGD:1320729 6480464 Diethylstilbestrol results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat diquat increases expression ISO RGD:1320730 6480464 Diquat results in increased expression of LPO mRNA CTD PMID:36851058 Lpo Rat epoxiconazole increases expression ISO RGD:1320730 6480464 epoxiconazole results in increased expression of LPO mRNA CTD PMID:35436446 Lpo Rat fenvalerate decreases expression ISO RGD:1320729 6480464 fenvalerate results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat folic acid multiple interactions ISO RGD:1320730 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LPO mRNA CTD PMID:22206623 Lpo Rat folic acid decreases expression ISO RGD:1320730 6480464 Folic Acid results in decreased expression of LPO mRNA CTD PMID:25629700 Lpo Rat fumonisin B1 decreases expression ISO RGD:1320729 6480464 fumonisin B1 results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat gabapentin decreases expression ISO RGD:1320729 6480464 Gabapentin results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat glyphosate decreases expression ISO RGD:1320729 6480464 Glyphosate results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat hydrogen peroxide multiple interactions ISO RGD:1320729 6480464 [LPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of Nitrites CTD PMID:22434701 Lpo Rat hydroxyurea decreases expression ISO RGD:1320729 6480464 Hydroxyurea results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of LPO mRNA CTD PMID:21396975 Lpo Rat lanthanum trichloride multiple interactions ISO RGD:1320729 6480464 [cerous chloride co-treated with lanthanum chloride] results in increased expression of LPO mRNA CTD PMID:28954213 Lpo Rat lanthanum trichloride increases expression ISO RGD:1320729 6480464 lanthanum chloride results in increased expression of LPO mRNA CTD PMID:28954213 Lpo Rat lipopolysaccharide multiple interactions ISO RGD:1320729 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LPO mRNA CTD PMID:35811015 Lpo Rat lipopolysaccharide decreases expression ISO RGD:1320729 6480464 Lipopolysaccharides results in decreased expression of LPO mRNA CTD PMID:35811015 Lpo Rat lycopene multiple interactions ISO RGD:1320730 6480464 lycopene inhibits the reaction [Diethylnitrosamine results in increased expression of LPO protein] CTD PMID:24144777 Lpo Rat medroxyprogesterone multiple interactions ISO RGD:1320729 6480464 [Estradiol co-treated with Medroxyprogesterone] affects the expression of LPO protein CTD PMID:16584521 Lpo Rat methotrexate affects expression ISO RGD:1320730 6480464 Methotrexate affects the expression of LPO mRNA CTD PMID:18502557 Lpo Rat N-nitrosodiethylamine multiple interactions ISO RGD:1320730 6480464 lycopene inhibits the reaction [Diethylnitrosamine results in increased expression of LPO protein] CTD PMID:24144777 Lpo Rat N-nitrosodiethylamine increases expression ISO RGD:1320730 6480464 Diethylnitrosamine results in increased expression of LPO protein CTD PMID:24144777 Lpo Rat nitrites multiple interactions ISO RGD:1320729 6480464 [LPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of Nitrites CTD PMID:22434701 Lpo Rat ochratoxin A decreases expression ISO RGD:1320729 6480464 ochratoxin A results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat ozone increases expression ISO RGD:1320729 6480464 Ozone results in increased expression of LPO mRNA CTD PMID:27206323 Lpo Rat paracetamol affects expression ISO RGD:1320730 6480464 Acetaminophen affects the expression of LPO mRNA CTD PMID:17562736 Lpo Rat paraquat decreases expression ISO RGD:1320730 6480464 Paraquat results in decreased expression of LPO mRNA CTD PMID:21688324 Lpo Rat paraquat increases expression ISO RGD:1320729 6480464 Paraquat results in increased expression of LPO mRNA CTD PMID:24141985 Lpo Rat paraquat multiple interactions ISO RGD:1320729 6480464 Paraquat inhibits the reaction [naringenin results in increased expression of LPO mRNA] CTD PMID:24561720 Lpo Rat paraquat multiple interactions ISO RGD:1320730 6480464 APOD protein affects the reaction [Paraquat results in decreased expression of LPO mRNA] CTD PMID:21688324 Lpo Rat pyrogallol multiple interactions EXP 6480464 acetovanillone inhibits the reaction [Pyrogallol results in increased activity of LPO protein] CTD PMID:35944648 Lpo Rat quartz increases expression EXP 6480464 Quartz results in increased expression of LPO mRNA CTD PMID:32976597 Lpo Rat quartz multiple interactions EXP 6480464 Tobacco Smoke Pollution promotes the reaction [Quartz results in increased expression of LPO mRNA] CTD PMID:32976597 Lpo Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1320729 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LPO mRNA CTD PMID:35811015 Lpo Rat silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LPO mRNA CTD PMID:22431001 Lpo Rat sodium arsenite increases expression ISO RGD:1320729 6480464 sodium arsenite results in increased expression of LPO mRNA CTD PMID:38568856 Lpo Rat sodium fluoride increases expression ISO RGD:1320729 6480464 Sodium Fluoride results in increased expression of LPO protein CTD PMID:9504181 Lpo Rat sulfadiazine decreases expression ISO RGD:1320729 6480464 Sulfadiazine results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of LPO mRNA CTD PMID:30012374 Lpo Rat titanium dioxide decreases methylation ISO RGD:1320730 6480464 titanium dioxide results in decreased methylation of LPO gene CTD PMID:35295148 Lpo Rat titanium dioxide increases methylation ISO RGD:1320730 6480464 titanium dioxide results in increased methylation of LPO gene CTD PMID:35295148 Lpo Rat valproic acid decreases methylation ISO RGD:1320729 6480464 Valproic Acid results in decreased methylation of LPO gene CTD PMID:29154799 Lpo Rat valproic acid decreases expression ISO RGD:1320729 6480464 Valproic Acid results in decreased expression of LPO mRNA CTD PMID:34748853 Lpo Rat vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of LPO gene CTD PMID:31079544
(S)-colchicine (ISO) (S)-naringenin (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP) 3,3',4,4',5-pentachlorobiphenyl (EXP) 4,4'-sulfonyldiphenol (ISO) 5-fluorouracil (ISO) acrylamide (EXP) aflatoxin B1 (EXP,ISO) apocynin (EXP) barium sulfate (EXP) benzidine (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) C60 fullerene (EXP) carbon nanotube (EXP) ceric oxide (EXP) cerium trichloride (ISO) CGP 52608 (ISO) cisplatin (ISO) clobetasol (ISO) copper atom (EXP) copper(0) (EXP) coumarin (ISO) diethylstilbestrol (ISO) diquat (ISO) epoxiconazole (ISO) fenvalerate (ISO) folic acid (ISO) fumonisin B1 (ISO) gabapentin (ISO) glyphosate (ISO) hydrogen peroxide (ISO) hydroxyurea (ISO) indole-3-methanol (EXP) lanthanum trichloride (ISO) lipopolysaccharide (ISO) lycopene (ISO) medroxyprogesterone (ISO) methotrexate (ISO) N-nitrosodiethylamine (ISO) nitrites (ISO) ochratoxin A (ISO) ozone (ISO) paracetamol (ISO) paraquat (ISO) pyrogallol (EXP) quartz (EXP) S-(1,2-dichlorovinyl)-L-cysteine (ISO) silicon dioxide (EXP) sodium arsenite (ISO) sodium fluoride (ISO) sulfadiazine (ISO) titanium dioxide (EXP,ISO) valproic acid (ISO) vinclozolin (EXP)
Lpo (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 73,104,170 - 73,124,683 (-) NCBI GRCr8 mRatBN7.2 10 72,606,950 - 72,626,220 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 72,606,944 - 72,626,535 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 77,217,402 - 77,236,990 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 76,722,350 - 76,741,938 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 72,186,856 - 72,206,440 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 75,100,385 - 75,120,247 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 75,100,385 - 75,120,247 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 74,982,141 - 75,002,010 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 76,099,137 - 76,118,724 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 76,113,946 - 76,141,334 (-) NCBI Celera 10 71,519,507 - 71,539,099 (-) NCBI Celera Cytogenetic Map 10 q26 NCBI
LPO (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 58,238,584 - 58,268,518 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 58,218,548 - 58,268,518 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 56,315,945 - 56,345,879 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 53,670,847 - 53,700,878 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 53,670,846 - 53,700,878 NCBI Celera 17 52,777,558 - 52,807,657 (+) NCBI Celera Cytogenetic Map 17 q22 NCBI HuRef 17 51,676,598 - 51,706,675 (+) NCBI HuRef CHM1_1 17 56,380,806 - 56,410,900 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 59,105,602 - 59,136,399 (+) NCBI T2T-CHM13v2.0
Lpo (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 87,697,254 - 87,716,750 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 87,697,254 - 87,719,115 (-) Ensembl GRCm39 Ensembl GRCm38 11 87,806,428 - 87,826,114 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 87,806,428 - 87,828,289 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 87,619,930 - 87,639,616 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 87,622,623 - 87,642,309 (-) NCBI MGSCv36 mm8 Celera 11 97,402,180 - 97,421,582 (-) NCBI Celera Cytogenetic Map 11 C NCBI cM Map 11 52.22 NCBI
Lpo (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955451 4,754,468 - 4,769,553 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955451 4,754,572 - 4,769,380 (-) NCBI ChiLan1.0 ChiLan1.0
LPO (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 74,388,763 - 74,440,991 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 79,201,492 - 79,252,142 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 52,315,674 - 52,344,007 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 57,171,304 - 57,199,735 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 57,171,310 - 57,199,735 (+) Ensembl panpan1.1 panPan2
LPO (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 9 32,898,370 - 32,927,141 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 9 32,899,406 - 32,925,842 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 9 32,135,588 - 32,163,081 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 9 33,705,179 - 33,732,704 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 9 33,706,203 - 33,732,625 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 9 32,491,378 - 32,518,405 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 9 32,774,813 - 32,802,295 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 9 32,868,304 - 32,895,803 (+) NCBI UU_Cfam_GSD_1.0
Lpo (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405602 32,229,640 - 32,253,635 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936490 4,821,910 - 4,840,018 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936490 4,821,421 - 4,838,377 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
LPO (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 34,525,127 - 34,554,176 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 34,525,113 - 34,554,031 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 36,259,233 - 36,286,755 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
LPO (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 35,132,781 - 35,182,571 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 35,133,311 - 35,158,976 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666077 5,947,771 - 5,973,970 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Lpo (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 54 Count of miRNA genes: 48 Interacting mature miRNAs: 51 Transcripts: ENSRNOT00000011402 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 631565 Hcuc4 Hepatic copper content QTL 4 4.15 liver copper amount (VT:0003065) liver copper weight to liver dry weight ratio (CMO:0001512) 10 66941813 73452992 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 152025224 Bw193 Body weight QTL 193 6.47 body mass (VT:0001259) 10 51663405 75085664 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 61449 Ciaa2 CIA Autoantibody QTL 2 7.1 blood autoantibody amount (VT:0003725) calculated serum anti-type 2 collagen antibody titer (CMO:0001279) 10 63221094 107211142 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1549831 Bss6 Bone structure and strength QTL 6 4 lumbar vertebra strength trait (VT:0010574) vertebra ultimate force (CMO:0001678) 10 57576521 102576521 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 2298548 Neuinf7 Neuroinflammation QTL 7 3.4 nervous system integrity trait (VT:0010566) spinal cord RT1-B protein level (CMO:0002132) 10 72224939 107211142 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2313103 Bss80 Bone structure and strength QTL 80 2 0.0001 tibia strength trait (VT:1000284) tibia midshaft endosteal cross-sectional area (CMO:0001716) 10 62057807 107057807 Rat 2293646 Bss25 Bone structure and strength QTL 25 10.96 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 10 69738412 107211142 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 2300172 Bmd57 Bone mineral density QTL 57 9.8 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 10 69738412 107211142 Rat 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 2.38 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 10 72224939 107211142 Rat 2313105 Bss79 Bone structure and strength QTL 79 1.8 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 62057807 107057807 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 1357344 Bp249 Blood pressure QTL 249 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 66743655 98003205 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 2306970 Anxrr22 Anxiety related response QTL 22 5.95 fear/anxiety-related behavior trait (VT:1000241) number of periods of voluntary immobility (CMO:0001045) 10 61345276 98211570 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2293663 Bss33 Bone structure and strength QTL 33 9.34 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 10 69738412 107211142 Rat 7387312 Bw125 Body weight QTL 125 3 0.0047 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight (CMO:0000356) 10 64890616 107211142 Rat 2312672 Insul15 Insulin level QTL 15 0.01 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 10 57134272 102134272 Rat 2317029 Aia19 Adjuvant induced arthritis QTL 19 2.98 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 66978955 107211142 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 2306793 Ean5 Experimental allergic neuritis QTL 5 4.7 nervous system integrity trait (VT:0010566) IFNG-secreting splenocyte count (CMO:0002122) 10 72552416 93995749 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 2317039 Aia6 Adjuvant induced arthritis QTL 6 4.31 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 66978955 107211142 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 0.0169 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 10 65927233 82565079 Rat 61396 Bp9 Blood pressure QTL 9 4.8 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68420376 107211142 Rat 70363 Bp71 Blood pressure QTL 71 0.04 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 61345276 81714865 Rat 61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 4.58 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 61345413 82564856 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 10450498 Bp384 Blood pressure QTL 384 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 67750049 107211142 Rat 6893366 Bw106 Body weight QTL 106 0.3 0.47 body mass (VT:0001259) body weight (CMO:0000012) 10 70199100 107211142 Rat 2293698 Bss43 Bone structure and strength QTL 43 5.33 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 10 59209888 104209888 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 2289985 Bp305 Blood pressure QTL 305 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 67502108 73579767 Rat 1354608 Cm33 Cardiac mass QTL 33 2.8 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 10 54809292 99809292 Rat 1558643 Cm44 Cardiac mass QTL 44 4.8 0.0000368 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 61345276 99703528 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 6893336 Cm75 Cardiac mass QTL 75 0.1 0.87 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 61345276 99703528 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 2312662 Slep8 Serum leptin concentration QTL 8 0.05 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 10 57134272 102134272 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 1642980 Bp300 Blood pressure QTL 300 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 68383129 107211142 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat 2312668 Scl65 Serum cholesterol level QTL 65 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 57134272 102134272 Rat
BF404752
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 72,606,967 - 72,607,087 (+) MAPPER mRatBN7.2 Rnor_6.0 10 75,100,409 - 75,100,528 NCBI Rnor6.0 Rnor_5.0 10 75,001,860 - 75,001,979 UniSTS Rnor5.0 RGSC_v3.4 10 76,099,161 - 76,099,280 UniSTS RGSC3.4 Celera 10 71,519,531 - 71,519,650 UniSTS Cytogenetic Map 10 q26 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
2
6
63
70
72
41
15
41
5
114
38
45
24
46
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000011402 ⟹ ENSRNOP00000011402
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 72,606,944 - 72,626,535 (-) Ensembl Rnor_6.0 Ensembl 10 75,100,385 - 75,120,247 (-) Ensembl
RefSeq Acc Id:
NM_001414336 ⟹ NP_001401265
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 73,104,188 - 73,123,456 (-) NCBI mRatBN7.2 10 72,606,950 - 72,626,220 (-) NCBI
RefSeq Acc Id:
XM_063268704 ⟹ XP_063124774
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 73,104,170 - 73,124,683 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000011402 ⟸ ENSRNOT00000011402
RefSeq Acc Id:
NP_001401265 ⟸ NM_001414336
- Peptide Label:
precursor
- UniProtKB:
A6HHV8 (UniProtKB/TrEMBL), D4A400 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063124774 ⟸ XM_063268704
- Peptide Label:
isoform X1
- UniProtKB:
A6HHV8 (UniProtKB/TrEMBL), D4A400 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Lpo
lactoperoxidase
Lpo_predicted
lactoperoxidase (predicted)
'predicted' is removed
2292626
APPROVED
2005-01-12
Lpo_predicted
lactoperoxidase (predicted)
Symbol and Name status set to approved
70820
APPROVED